Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinopathy associated with high-dose interferon alfa-2b therapy.

C Hejny1, P Sternberg, D H Lawson

  • 1Department of Ophthalmology, Emory Eye Center and Emory University School of Medicine, Atlanta, Georgia 30322, USA.

American Journal of Ophthalmology
|June 1, 2001
PubMed
Summary

High-dose interferon alfa-2b therapy for melanoma can cause retinopathy, potentially leading to vision loss. Patients require monitoring for this side effect, especially with higher treatment dosages.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chinese medicine and constructivism-a new way in psychotherapy].

Der Nervenarzt·2018
Same author

Low-temperature behaviour of K<sub>2</sub>Sc[Si<sub>2</sub>O<sub>6</sub>]F: determination of the lock-in phase and its relationships with fresnoite- and melilite-type compounds.

Acta crystallographica Section B, Structural science, crystal engineering and materials·2017
Same author

SU-E-T-429: Image-Guided Eye Plaque Brachytherapy Optimization: Implications for Patients at 2-Year Follow-up.

Medical physics·2017
Same author

The design and validation of an optical coherence tomography-based classification system for focal vitreomacular traction.

Eye (London, England)·2016
Same author

Glucocorticoid sensitivity in Behçet's disease.

Endocrine connections·2013
Same author

Detecting adverse drug reactions - a concise updateI. Cohort and case control studies.

The International journal of risk & safety in medicine·2013

Area of Science:

  • Ophthalmology
  • Oncology
  • Pharmacology

Background:

  • High-dose interferon alfa-2b is used for adjuvant treatment of high-risk melanoma.
  • Ocular side effects of this therapy require further investigation.

Observation:

  • Seven patients receiving high-dose interferon alfa-2b developed retinopathy.
  • Retinopathy presented with cotton-wool spots and/or retinal hemorrhages.
  • Two patients experienced severe vision loss, while five had resolution after treatment cessation.

Findings:

  • Interferon alfa-2b therapy is associated with an increased risk of retinopathy.
  • Higher dosages of interferon alfa-2b may correlate with a greater risk.
  • Severe vision loss is a potential complication of this retinopathy.

Related Experiment Videos

Implications:

  • Patients undergoing interferon alfa-2b therapy need regular ocular monitoring.
  • Early detection and treatment cessation may prevent severe vision loss.
  • The role of co-administered medications like paroxetine in retinopathy incidence is unclear and warrants further study.